Home / Business and Economy / Ireland's Pharma Empire: Boom to Bust Risk?
Ireland's Pharma Empire: Boom to Bust Risk?
1 Apr
Summary
- Ireland is now the world's third largest pharmaceutical exporter.
- Medicines constitute approximately 20% of Ireland's GDP.
- The nation's tax base heavily relies on a few multinational drugmakers.
Over the past fifty years, Ireland has transformed into a global pharmaceutical powerhouse, securing its position as the world's third-largest exporter of medicines. These vital products now contribute significantly to the nation's economy, accounting for approximately 20% of Ireland's Gross Domestic Product (GDP).
This remarkable growth has created a substantial economic reliance on the pharmaceutical sector. A notable share of Ireland's tax revenue is increasingly generated by a small number of major multinational drug companies. This dependence introduces vulnerability, as the country navigates potential risks associated with tariffs, patent expirations, and global geopolitical shifts.
